• GSK621: AMPK Agonist Workflows for AML & Immunometabolic Res

  2026-04-20

  GSK621, a potent AMPK agonist from APExBIO, empowers acute myeloid leukemia and tumor immunometabolism researchers with reproducible, high-sensitivity pathway activation. Discover protocol enhancements, troubleshooting strategies, and novel applications leveraging recent breakthroughs in macrophage metabolic reprogramming.

• MEK1/2 and c-Myc:MAX Regulate TERT Repression in hESCs

  2026-04-20

  The referenced study uncovers a mechanistic link between MEK1/2-ERK signaling and the c-Myc:MAX transcriptional complex in maintaining TERT expression in human embryonic stem cells (hESCs). By showing that disruption of c-Myc:MAX dimerization rapidly induces repressive chromatin at the TERT promoter, this work advances our molecular understanding of telomerase regulation and identifies new targets for stem cell and telomere biology research.

• Deep Learning Uncovers Cardiotoxicity in iPSC-CM Screens

  2026-04-19

  This study demonstrates a scalable deep learning approach for detecting drug-induced cardiotoxicity in high-content screens using human iPSC-derived cardiomyocytes. The work enables earlier identification of cardiotoxic liabilities in drug discovery, guiding safer and more efficient therapeutic development.

• Fludarabine as a Precision Genomic Tool in Leukemia Research

  2026-04-18

  Explore how Fludarabine, a potent DNA synthesis inhibitor, is advancing leukemia and multiple myeloma research through integration with genomic profiling and apoptosis assays. This article offers a unique, evidence-based perspective on optimizing Fludarabine’s use in translational oncology.

• Bay 11-7821 (BAY 11-7082): Precision IKK Inhibitor for NF-κB

  2026-04-17

  Bay 11-7821 (BAY 11-7082) is a selective IKK inhibitor that blocks NF-κB signaling with an IC50 of 10 μM, making it a gold-standard tool for inflammatory pathway and apoptosis research. This article details its mechanism, evidence, and protocol parameters for reproducible studies in cancer and immunology.

• GKT137831: Dual NADPH Oxidase Nox1/Nox4 Inhibitor in Redox R

  2026-04-16

  GKT137831 enables targeted inhibition of Nox1 and Nox4 NADPH oxidase isoforms, making it an essential tool for dissecting oxidative stress mechanisms in disease models. Discover workflow-enhancing protocols, troubleshooting insights, and translational advantages validated by recent breakthroughs in redox biology.

• Safe DNA Gel Stain: Sensitive, Safer DNA and RNA Gel Stain W

  2026-04-15

  Safe DNA Gel Stain from APExBIO elevates nucleic acid detection with high sensitivity and dramatically reduced mutagenicity. Its compatibility with blue-light imaging not only protects users but also enhances cloning success, making it the clear choice for modern molecular biology labs.

• Optimizing NF-κB Pathway Studies with QNZ (EVP4593): Protoco

  2026-04-14

  QNZ (EVP4593) offers nanomolar potency for modulating the NF-κB signaling pathway in inflammation and neurodegenerative disease models. This guide translates recent mechanistic insights into actionable workflows, troubleshooting, and advanced applications, empowering researchers to maximize the value of QNZ in both cell-based and in vivo studies.

• Nigericin Sodium Salt: Practical Guidance for Ion Transport

  2026-04-13

  Nigericin sodium salt is a potassium ionophore used to modulate ion gradients and cytoplasmic pH in cell-based assays. It is particularly suited to workflows requiring selective K+/H+ exchange, platelet aggregation modulation, and studies of lead (Pb2+) ion transport. Researchers should avoid its use in diagnostic or therapeutic settings and adhere strictly to solubility and handling protocols for reliable results.

• Dual-Action Kinase Inhibitors Accelerate p38α MAPK Dephospho

  2026-04-12

  The reference paper reveals that certain kinase inhibitors, by stabilizing specific inactive conformations of p38α MAP kinase, not only inhibit kinase activity but also markedly enhance phosphatase-mediated dephosphorylation of the activation loop. This dual-action mechanism suggests a new avenue for designing more potent and specific kinase inhibitors for inflammation and vascular research.

• Ridaforolimus (Deforolimus, MK-8669): Scenario-Driven Lab So

  2026-04-12

  This authoritative guide addresses real-world challenges in cell-based assays, illustrating how Ridaforolimus (Deforolimus, MK-8669) (SKU B1639) ensures reproducibility, sensitivity, and workflow compatibility in cancer and senescence research. Benchmarked protocols and practical Q&A blocks empower researchers to optimize experimental design and data reliability.

• Applied Angiotensin I: Workflows, Troubleshooting, and RAS I

  2026-04-11

  Harness the translational power of Angiotensin I (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu) in renin-angiotensin system research with evidence-based workflows and optimized protocols. Discover comparative advantages, troubleshooting strategies, and actionable guidance rooted in the latest molecular findings.

• Protease Inhibitor Cocktail EDTA-Free: Precision in Protein

  2026-04-11

  Preserve protein integrity with the Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO), designed for workflows sensitive to divalent cations and post-translational modifications. Explore its applied advantages in advanced stem cell and phosphorylation studies, with actionable protocol guidance and troubleshooting tips for reproducible results.

• 2-APB: A Precise IP3R Antagonist for Calcium Signaling Re...

  2026-04-10

  2-APB (2-aminoethoxydiphenyl borate) is a gold-standard IP3 receptor antagonist and calcium signaling inhibitor, enabling reliable modulation of intracellular calcium dynamics in diverse research settings. With robust inhibition profiles and proven effectiveness in apoptosis and oxidative stress studies, APExBIO’s 2-APB sets a reproducible benchmark for dissecting cell signaling pathways.

• Probenecid: Mechanistic Mastery and Strategic Guidance fo...

  2026-04-09

  Explore how Probenecid (4-(dipropylsulfamoyl)benzoic acid), an advanced inhibitor of organic anion transporters, MRPs, and pannexin-1 channels, is revolutionizing multidrug resistance reversal and neuroprotection strategies. This thought-leadership article bridges cutting-edge mechanistic science with actionable insights for translational researchers, highlighting novel immunometabolic intersections, integration with recent CD8+ T cell metabolic discoveries, and positioning APExBIO Probenecid as an indispensable tool for next-generation cancer and neuroscience workflows.

407 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page